Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Case Reports in Medicine|May 7, 2014
A case of secondary leukemia subsequent to myelodysplastic syndromes successfully treated with azacitidineTakahiro Kumode, Ayano Fukui, Go Eguchi, et al.Microbiology and Immunology|January 6, 2023
Establishment of a system to quantify wild-type herpes simplex virus-induced cell-cell fusion reveals a role of N-glycosylation of HSV-1 envelope glycoprotein B in cell-cell fusionAyano Fukui, Yuhei Maruzuru, Kosuke Takeshima, et al.Veterinary Immunology and Immunopathology|January 1, 2021
HSP110 expression in canine mammary gland tumor and its correlation with histopathological classification and gradeSatoru Okada, Masaru Furuya, Ayano Fukui-Kaneshige, et al.Veterinary Immunology and Immunopathology|August 22, 2015
Localization of heat shock protein 110 in canine mammary gland tumorsSatoru Okada, Masaru Furuya, Shigeo Takenaka, et al.Journal of Virology|October 1, 2020
Role of Phosphatidylethanolamine Biosynthesis in Herpes Simplex Virus 1-Infected Cells in Progeny Virus Morphogenesis in the Cytoplasm and in Viral Pathogenicity In VivoJun Arii, Ayano Fukui, Yuta Shimanaka, et al.Mbio|June 27, 2023
Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulenceAyano Fukui, Yuhei Maruzuru, Shiho Ohno, et al.Internal Medicine (Tokyo, Japan)|March 29, 2019
Intravascular Lymphoma Presenting as a Cavernous Sinus TumorShigeru Kawai, Takeshi Okuda, Ayano Fukui, et al.International Journal of Hematology|November 12, 2024
CD34+ and CD34- MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cellsAyano Fukui-Morimoto, Kentaro Serizawa, Ko Fujimoto, et al.International Journal of Hematology|February 8, 2022
CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescenceKentaro Serizawa, Hirokazu Tanaka, Takeshi Ueda, et al.Journal of Virology|November 12, 2020
Prohibitin-1 Contributes to Cell-to-Cell Transmission of Herpes Simplex Virus 1 via the MAPK/ERK Signaling PathwayMizuki Watanabe, Jun Arii, Kosuke Takeshima, et al.Pageof 1